Intellia Therapeutics
NTLA
NTLA
130 hedge funds and large institutions have $557M invested in Intellia Therapeutics in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 44 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
+18
Holders Change %
+16.07%
% of All Funds
2.98%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
37
Increased
44
Reduced
27
Closed
18
Calls
$4M
Puts
$9.36M
Net Calls
-$5.36M
Net Calls Change
-$7.67M
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$47M |
| 2 |
Morgan Stanley
New York
|
+$33.3M |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$12.4M |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.15M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.55M |
Top Sellers
| 1 |
AVAI
Atlas Venture Associates IX
Boston,
Massachusetts
|
-$27.4M |
| 2 |
O
OrbiMed
New York
|
-$25.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.3M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$10.3M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$6.57M |
